Recruiting NCT06729840
Intralesional Treatment of Keloids
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Injection.
- Who it may be relevant to
- Registry conditions: Scar, Hypertrophic. Basic parameters: 18 years — 60 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Vitamin D in Keloids
Overview
Intralesional injection in treatment of keloid
Detailed description
Our study will include 45 patient diveded into three groups , follow up will done before each session , 3month after the last session using photographing assessment , scoring , dermoscope
Interventions
- Drug Injection
Vitamin D , botox , tramcinolone intralesionally injected in keloid
Primary outcome measures
- Posas score [Time frame: One session every two weeks total duration 3 months]
Eligibility criteria
Inclusion criteria
Both sex aged 18-60 having keloid
\-
Exclusion criteria
- pregnancy , lactation Skin disease
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Sohag university hospital — Sohag
Identifiers
NCT: NCT06729840 · Soh-Med--24-11-05MS